Abbott has introduced the RealTime HCV Genotype II test, the first FDA-approved hepatitis C virus (HCV) genotyping test. The RealTime HCV Genotype II test determines the specific strain of the HCV ...
HealthDay News — The FDA has approved a new test to help healthcare providers identify the genotype of a person’s hepatitis C infection. The Abbott RealTime HCV ...
It can be used to screen adults as a method to detect the disease in progeny. Osmetech received FDA clearance for its eSensor® Cystic Fibrosis Genotyping Test for use on the eSensor® XT-8 System. This ...
ELMWOOD PARK, N.J.--(BUSINESS WIRE)-- BioReference Laboratories, Inc. (NASDAQ: BRLI) and its GenPath Oncology business unit and through its exclusive commercialization agreement with the Massachusetts ...
The U.S. Food and Drug Administration today approved a test that identifies the genotypeof hepatitis C virus (HCV) that apatientis carrying. The Abbott RealTime HCV ...
FDA this week approved its first genotyping test for patients with hepatitis C virus (HCV), Abbott’s RealTime HCV Genotype II. The test can differentiate genotypes ...
TROY, Mont.--(BUSINESS WIRE)-- In an April 22, 2011 letter to FDA Commissioner; Dr. Margaret Hamburg, Norma Erickson on behalf of the SaneVax Inc. Board of Directors, criticized the FDA for not ...
The US Food and Drug Administration (FDA) today approved the first genotyping test for patients with hepatitis C virus (HCV) that can better enable physicians to select the most appropriate treatment.
ELMWOOD PARK, N.J.--(BUSINESS WIRE)-- BioReference Laboratories, Inc. (NASDAQ: BRLI) and its GenPath Oncology business unit and through its exclusive commercialization agreement with the Massachusetts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback